期刊文献+

格尔德霉素对人卵巢癌细胞SKOV3增殖和凋亡的影响及其机制探讨 被引量:1

Effects of geldanamycin on cell proliferation and apoptosis of human ovarian cancer cell line SKOV3 and their mechanism
原文传递
导出
摘要 目的:研究格尔德霉素(geldanamycin,GA)对人卵巢癌SKOV3细胞的体外抑制作用,探讨GA抑制SKOV3细胞增殖及诱导其凋亡的可能机制。方法:MTT法检测GA单独或联合顺铂(cisplatin)对SKOV3细胞的增殖抑制作用;FCM法检测GA作用后SKOV3细胞周期及凋亡率的变化;分别应用免疫细胞化学法(immunocytochemistory,ICC)和FCM法检测GA处理SKOV3细胞48h后细胞内Akt、Raf-1蛋白的表达变化。结果:GA对SKOV3细胞的体外增殖可产生明显的抑制作用(P<0.05),该作用随着GA浓度的增高和作用时间的延长而增强。而且,GA可增强顺铂对SKOV3细胞的增殖抑制作用,在一定浓度范围内随着GA浓度的增高,两药联合应用对SKOV3细胞的增殖抑制作用越强。经0~2000nmol/L GA作用SKOV3细胞48h后,G2/M期细胞逐渐增多,细胞凋亡率也显著升高(P<0.05)。ICC和FCM法检测结果均表明,经0~2000nmol/L GA处理48h后,SKOV3细胞中Akt、Raf-1蛋白的表达水平随着药物浓度增高而逐渐降低(P<0.05)。结论:GA能够对卵巢癌SKOV3细胞产生明显的体外增殖抑制作用,并诱导其凋亡,其作用机制可能与下调卵巢癌细胞中Akt和Raf-1蛋白表达相关。 Objective: To investigate the cytotoxic effects of geldanamycin on human ovarian cancer SKOV3 cells, and to explore the possible mechanisms of apoptosis and cell proliferation inhibition of SKOV3 cells induced by geldanamycin. Methods: MTT method was performed to evaluate the inhibitory effects of geldanamycin alone or in combination with cisplatin on proliferation of SKOV3 cells. Cell cycle and apoptosis rate of SKOV3 cells treated with geldanamycin were detected by flow cytometry. The expressions of Akt and Raf-1 proteins were examined by immunocytochemistry and flow cytometry. Results: The proliferation of SKOV3 cells was inhibited by different concentrations of geldanamycin in a time- and dose-dependent manners (P〈0.05). Different concentrations of geldanamycin strengthened the inhibitory effect of cisplatin on proliferation of SKOV3 cells, and this inhibitory effect was strengthened with the increased concentration of geldanamycin within a certain concentration range. The apoptosis rate of SKOV3 cells was raised up gradually after treatment with 0-2 000 nmol/L geldanamycin for 48 h, and the number of cells in G2/M phase was increased significantly (P〈0.05). The results of immunocytochemistry and flow cytometry showed that the expressions of Akt and Raf-1 proteins in SKOV3 cells induced by geldanamycin were significantly down-regulated in a dose-dependent manner (P〈 0.05). Conclusion: Geldanamycin can inhibit the cell proliferation and induce the apoptosis of human ovarian cancer SKOV3 cells in vitro, which may be associated with downregulation of the expressions of Akt and Raf-1 proteins.
出处 《肿瘤》 CAS CSCD 北大核心 2011年第10期899-905,共7页 Tumor
基金 河北省教育厅普通高校强势特色学科项目[编号:冀教高(2005)52号] 河北省医学科学研究重点课题计划项目(编号:20090166)
关键词 卵巢肿瘤 细胞增殖 细胞凋亡 基因表达 顺铂 格尔德霉素 AKT RAF-1 Ovarian neoplasms Cell proliferation Apoptosis Gene expression Cisplatin Geldanamycin Akt Raf-1
  • 相关文献

参考文献11

  • 1BEREK J S. Berek and Novak's gynecology[M]. 14th ed. Philadelphia: Lippincott Williams & Wilkins, a Wolters Kluwer business, 2008: 952.
  • 2HAHN J S. The Hsp90 chaperone machinery: from structure to drug development[J]. BMB Rep, 2009, 42(10): 623-630.
  • 3金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 4GATALICA Z, LILLEBERG S L, VRANIC S, etal. Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms[J]. HumPathol, 2009, 40(12): 1813-1819.
  • 5余畅,邓华瑜.HSP 90与survivin在人乳腺癌细胞中的作用及机制探讨[J].肿瘤,2007,27(10):791-794. 被引量:4
  • 6SAYERS T J. Targeting the extrinsic apoptosis signaling pathway for cancer therapy[J]. Cancer Immunol Immunother, 2011,60(8): 1173-1180.
  • 7HUANG K H, VEAL J M, FADDEN R P, et al. Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective andorally active antitumor agents[J]. J Med Chem, 2009, 52(14): 4288-4305.
  • 8SAMADI A, LOO P, MUKERJI R, et al. A novel HSP90 modulator with selective activity against thyroid cancers in vitro[J]. Surgery, 2009, 146(6):1196-1207.
  • 9REDLAK M J, MILLER T A. Targeting PI3K/Akt/ HSP90 signaling sensitizes gastric cancer cells to deoxycholate-induced apoptosis[J]. Dig Dis Sci,2011, 56(2): 323-329.
  • 10SIRIWARDANA G, BRADFORD A, COY D, et al. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasinghormone via Ras, Raf, and mitogen-activated protein kinase[J]. Mol Endocrinol, 2006, 20(9): 2010-2019.

二级参考文献11

  • 1AMBROSINI G, ADIDA C, ALTIENI D C. A novel anti-apoptosis gene, survivin expressed in cancer and lymphoma[J]. Nat Med, 1997,3 (8) :917-921.
  • 2KANDA N, SENO H, KONDA Y, et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells [ J ]. Oncogene, 2004,23 ( 28 ) : 4921-4929.
  • 3JOHANNES B, SALNITSKI V P, GUNGA H C, et al. Regulatory change at high altitudes in comparison with post-space-flight reaction[J]. J Gravit Physiol,1999,6( 1 ) :45-46.
  • 4PRATT W B, TOFT D O. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery [J]. Exp Biol Med (Maywood) ,2003,228(2) :111-133.
  • 5EVAN G I, VOUSDEN K H. Proliferation, cell cycle and apoptosis in cancer[ J]. Nature,2001,411 (6835) :342-348.
  • 6LSAACS JS,XU W,NECKERS L. Heat shock protein 90 as a molecular target for cancer therapeutics [ J ]. Cancer Cell, 2003,3 (3) :213-217.
  • 7GAMIER C, LAFITTE D,TSVETKOV P O, et al. Binding of ATP to heat shock protein 90: evidence for an ATP-binding site in the C-terminal domain [ J ]. J Biol Chem, 2002,277 ( 14 ) : 12208- 12214.
  • 8BROMBERG J F, HORVATH C M, BESSER D, et al. Stat3 activation is required for cellular transformation by v-src [ J ]. Mol Cell Biol, 1998,18(5 ) :2553-2558.
  • 9BROMBERG J F, WRZESZCZYNSKA M H, DEVGAN G, et al. Stat3 as an oncogene [ J ]. Cell, 1999,98 ( 3 ) :295-303.
  • 10BUETTNER R, MORAL B, JOVE R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention [ J ]. Clin Cancer Res ,2002,8 (4) :945-954.

共引文献120

同被引文献3

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部